ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 102 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $101,187,000 | +59.5% | 1,088,735 | +2.2% | 0.01% | +33.3% |
Q3 2021 | $63,434,000 | -13.4% | 1,065,226 | -0.9% | 0.01% | -10.0% |
Q2 2021 | $73,274,000 | +3.3% | 1,074,410 | +5.1% | 0.01% | -9.1% |
Q1 2021 | $70,925,000 | +0.3% | 1,022,134 | +11.1% | 0.01% | -8.3% |
Q4 2020 | $70,686,000 | +9.2% | 920,037 | +6.3% | 0.01% | -7.7% |
Q3 2020 | $64,703,000 | +19.2% | 865,133 | +0.3% | 0.01% | +8.3% |
Q2 2020 | $54,292,000 | +73.3% | 862,476 | +15.6% | 0.01% | +50.0% |
Q1 2020 | $31,323,000 | -50.7% | 745,805 | -46.7% | 0.01% | +14.3% |
Q4 2019 | $63,558,000 | +105.6% | 1,399,362 | +107.2% | 0.01% | 0.0% |
Q3 2019 | $30,910,000 | -20.8% | 675,352 | +1.5% | 0.01% | -22.2% |
Q2 2019 | $39,013,000 | +43.0% | 665,424 | +9.4% | 0.01% | +28.6% |
Q1 2019 | $27,276,000 | -38.1% | 608,453 | -46.2% | 0.01% | 0.0% |
Q4 2018 | $44,036,000 | +82.9% | 1,130,578 | +116.1% | 0.01% | 0.0% |
Q3 2018 | $24,078,000 | +9.9% | 523,219 | +4.1% | 0.01% | 0.0% |
Q2 2018 | $21,915,000 | +24.7% | 502,640 | +12.9% | 0.01% | +16.7% |
Q1 2018 | $17,581,000 | +47.4% | 445,099 | +26.7% | 0.01% | +50.0% |
Q4 2017 | $11,929,000 | +38.0% | 351,181 | +3.6% | 0.00% | +33.3% |
Q3 2017 | $8,644,000 | +97.9% | 338,995 | +31.0% | 0.00% | +50.0% |
Q2 2017 | $4,367,000 | – | 258,862 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |